Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin

Brinkmann T, Korfer R, Wenzel H, Tschesche H, Kleesiek K (1997)
IMMUNOPHARMACOLOGY 35(3): 221-228.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Brinkmann, T; Korfer, R; Wenzel, HerbertUniBi; Tschesche, HaraldUniBi; Kleesiek, KnutUniBi
Einrichtung
Fakultät für Chemie > Biochemie I
Abstract / Bemerkung
We detected anti-aprotinin antibodies by an enzyme immunoassay in serum of a 33 year old man who showed anaphylactic reactions during heart transplantation under aprotinin reexposition. The antibodies were isolated by affinity chromatography by aprotinin immobilized on CNBr activated Sepharose. The crossreactivity was tested by a competitive enzyme immunoassay (50% inhibition) against different aprotinin homologues and two human Kunitz-type protease inhibitors, bikunin and TFPI. In comparison with native aprotinin (immunoreactivity = 100%) the crossreaction of the homologue [Arg(15)]aprotinin was 76%, of [Val(15)]aprotinin 15% and of isoaprotinin 1, [Ala(14,38)]aprotinin and [seco15/16]aprotinin less than 10%. An immunoreactivity with bikunin and TFPI was not detected, Similar results were obtained with polyclonal anti-aprotinin antibodies from rabbit. Our results show that human anti-aprotinin antibodies are mainly directed against the reactive site of aprotinin, From this we conclude that the reactive site exposes the major epitope resulting in a major target site for antibodies in a species independent way, and therefore, it is obvious that the recombinant aprotinin homologue [Arg(15)]aprotinin, which is scheduled for therapy in open-heart surgery, will have similar immunogenic effects as native aprotinin.
Stichworte
open-heart surgery; immunoresponse; anaphylactic shock; aprotinin
Erscheinungsjahr
1997
Zeitschriftentitel
IMMUNOPHARMACOLOGY
Band
35
Ausgabe
3
Seite(n)
221-228
ISSN
0162-3109
Page URI
https://pub.uni-bielefeld.de/record/1628000

Zitieren

Brinkmann T, Korfer R, Wenzel H, Tschesche H, Kleesiek K. Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin. IMMUNOPHARMACOLOGY. 1997;35(3):221-228.
Brinkmann, T., Korfer, R., Wenzel, H., Tschesche, H., & Kleesiek, K. (1997). Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin. IMMUNOPHARMACOLOGY, 35(3), 221-228. https://doi.org/10.1016/S0162-3109(96)00148-8
Brinkmann, T, Korfer, R, Wenzel, Herbert, Tschesche, Harald, and Kleesiek, Knut. 1997. “Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin”. IMMUNOPHARMACOLOGY 35 (3): 221-228.
Brinkmann, T., Korfer, R., Wenzel, H., Tschesche, H., and Kleesiek, K. (1997). Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin. IMMUNOPHARMACOLOGY 35, 221-228.
Brinkmann, T., et al., 1997. Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin. IMMUNOPHARMACOLOGY, 35(3), p 221-228.
T. Brinkmann, et al., “Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin”, IMMUNOPHARMACOLOGY, vol. 35, 1997, pp. 221-228.
Brinkmann, T., Korfer, R., Wenzel, H., Tschesche, H., Kleesiek, K.: Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin. IMMUNOPHARMACOLOGY. 35, 221-228 (1997).
Brinkmann, T, Korfer, R, Wenzel, Herbert, Tschesche, Harald, and Kleesiek, Knut. “Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg(15)]aprotinin”. IMMUNOPHARMACOLOGY 35.3 (1997): 221-228.

9 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

[What is the reality of anaphylactoid reactions during anaesthesia? Classification, prevalence, clinical features, drugs involved and morbidity and mortality].
Mertes PM, Karila C, Demoly P, Auroy Y, Ponvert C, Lucas MM, Malinovsky JM., Ann Fr Anesth Reanim 30(3), 2011
PMID: 21353759
Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
Sun Z, Lu W, Jiang A, Chen J, Tang F, Liu JN., Protein Expr Purif 65(2), 2009
PMID: 19152836
Severe intraoperative anaphylactic reaction: aprotinin and rocuronium.
Santos Silva F., J Cardiothorac Vasc Anesth 22(5), 2008
PMID: 18922434
Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions.
Beierlein W, Scheule AM, Dietrich W, Ziemer G., Ann Thorac Surg 79(2), 2005
PMID: 15680884
What price support? Ventricular assist device induced systemic response.
Thompson LO, Loebe M, Noon GP., ASAIO J 49(5), 2003
PMID: 14524557
[What is the real risk of drug hypersensitivity in anesthesia? Incidence. Clinical aspects. Morbidity-mortality. Substances responsible].
Laxenaire MC., Ann Fr Anesth Reanim 21 Suppl 1(), 2002
PMID: 12091986
[Are there risk factors of allergic reactions related to patient factors, to drugs, techniques of use? Predictive indications].
Malinovsky JM, Vervloet D, Laxenaire MC., Ann Fr Anesth Reanim 21 Suppl 1(), 2002
PMID: 12091979
[Can prevention of allergic risk be assured with preanesthetic medication].
Dewachter P., Ann Fr Anesth Reanim 21 Suppl 1(), 2002
PMID: 12091980
[Allergic risk of aprotinin].
Laxenaire MC, Dewachter P, Pecquet C., Ann Fr Anesth Reanim 19(2), 2000
PMID: 10730171

40 References

Daten bereitgestellt von Europe PubMed Central.

The disulfide linkages in kallikrein inactivator of bovine lung.
Anderer FA, Hornle S., J. Biol. Chem. 241(7), 1966
PMID: 5296424
Expression, isolation and characterization of recombinant [Arg15,Glu52]aprotinin
Auerswald, Biol Chem HS 369(), 1988
Preparation of chemically 'mutated' aprotinin homologues by semisynthesis. P1 substitutions change inhibitory specificity.
Beckmann J, Mehlich A, Schroder W, Wenzel HR, Tschesche H., Eur. J. Biochem. 176(3), 1988
PMID: 2458925
Reduction in blood loss and blood use after cardiopulmonary bypass with highdose aprotinin (Trasylol)
Bidstrup, J Thorac Cardiov Sur 97(), 1989
Design of an aprotinin variant with inhibitory activity against chymotrypsin and cathepsin G by recombinant DNA technology
Brinkmann, Biol Chem HS 371(), 1990
Recombinant aprotinin variants with new inhibitory activity against cathepsin G
Brinkmann, Eur J Biochem 203(), 1991
Inhibition of human lung tryptase and rat mast cell chymases by recombinant aprotinin homologues
Brinkmann, Chem Peptides Proteins 5–6(), 1993
Anaphylactic shock during the use of high doses of aprotinin in cardiac surgery
Cottineau, Ann Fr Anest Rean. 12(), 1993
General pharmacology of r-aprotinin in rats, cats and pigs
Dall, 1989
Anaphylactic reaction to aprotinin during cardiac surgery
Dewachter, Anesthesia 48(), 1993
Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery.
Diefenbach C, Abel M, Limpers B, Lynch J, Ruskowski H, Jugert FK, Buzello W., Anesth. Analg. 80(4), 1995
PMID: 7534456
The effect of recombinant aprotinin on t-PA-induced bleeding in rats.
Erhardtsen E, Bregengaard C, Hedner U, Diness V, Halkjaer E, Petersen LC., Blood Coagul. Fibrinolysis 5(5), 1994
PMID: 7532446
Reduction of blood transfusion requirement in open-heart surgery by administration of high dose of aprotinin: preliminary results
Fraedrich, Thorac Cardiov Surg 37(), 1989
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.
Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ Jr., Nature 338(6215), 1989
PMID: 2927510
Recombinant aprotinin in coronary artery bypass graft operations.
Green D, Sanders J, Eiken M, Wong CA, Frederiksen J, Joob A, Palmer A, Trowbridge A, Woodruff B, Moerch M., J. Thorac. Cardiovasc. Surg. 110(4 Pt 1), 1995
PMID: 7475162
Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
Havel M, Teufelsbauer H, Knobl P, Dalmatiner R, Jaksch P, Zwolfer W, Muller M, Vukovich T., J. Thorac. Cardiovasc. Surg. 101(6), 1991
PMID: 1710009
The basic trypsin inhibitor of bovine pancreas. V. The disulfide linkages.
Kassell B, Laskowski M Sr., Biochem. Biophys. Res. Commun. 20(4), 1965
PMID: 5860161
Effect of recombinant aprotinin on platelet activation in patients undergoing open heart surgery.
Matzdorff AC, Green D, Cohen I, Bauer KD., Haemostasis 23(6), 1993
PMID: 7518406

AUTHOR UNKNOWN, 1993
Routine intraoperative application of high-dose aprotinin in open heart surgery in adults: antibody formation after first exposure
Pfannschmidt, Curr Med Res Opinion 13(), 1995
Effect of aprotinin on need for blood transfusion after repeat open-heart surgery
Royston, Lancet 335(), 1987
Aprotinin prevents bleeding and has effects on platelets and fibrinolysis
Royston, J Cardiothorac Vasc Anesth 5(Suppl 1), 1991
High-dose aprotinin therapy: a review of the first five years' experience.
Royston D., J. Cardiothorac. Vasc. Anesth. 6(1), 1992
PMID: 1371939
Untersuchungen zur Antigenität von Trasylol in der offenen Herzchirurgie
Ruskowski, Thorac Cardiov Surg 41(Suppl. I), 1993

AUTHOR UNKNOWN, 1989
On the size of the active site in proteases. I. Papain.
Schechter I, Berger A., Biochem. Biophys. Res. Commun. 27(2), 1967
PMID: 6035483
Enzymatic resynthesis of the ‘reactive site’ bond in the modified aprotinin derivatives [seco 15/16]aprotinin and [Di-seco 15/16, 39/40]aprotinin
Schnabl, Biol Chem H-S 369(), 1988
Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement.
Schulze K, Graeter T, Schaps D, Hausen B., Eur J Cardiothorac Surg 7(9), 1993
PMID: 7692900
Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
Scott CF, Wenzel HR, Tschesche HR, Colman RW., Blood 69(5), 1987
PMID: 2436687
Pyroglutamyl-aprotinin, a new aprotinin homologue from bovine lungs - isolation, properties, sequence analysis and characterization using 1H nuclear magnetic resonance in solution
Siekmann, Biol Chem HS 368(), 1983
Characterization and sequence determination of six aprotinin homologues from bovine lungs
Siekmann, Biol Chem HS 369(), 1988
Immunological characterization of natural and semi-synthetic aprotinin variants
Siekmann, Biol Chem HS 370(), 1989
Semisynthetic engineering of proteinase inhibitor homologues.
Tschesche H, Beckmann J, Mehlich A, Schnabel E, Truscheit E, Wenzel HR., Biochim. Biophys. Acta 913(1), 1987
PMID: 2437960
Semisynthetic arginine-15-aprotinin, an improved inhibitor for human plasma kallikrein.
Tschesche H, Beckmann J, Mehlich A, Feldmann A, Wenzel HR, Scott CF, Colman RW., Adv. Exp. Med. Biol. 247B(), 1989
PMID: 2481943
Clinical application of inhibitors of fibrinolysis.
Verstraete M., Drugs 29(3), 1985
PMID: 2580684
Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography.
Wachter E, Hochstrasser K., Hoppe-Seyler's Z. Physiol. Chem. 362(10), 1981
PMID: 6171496
Determination of xylosyltransferase activity in serum using recombinant human bikunin as acceptor
Weilke, Clin Chem (), 1996
Potentials of high-performance ion-exchange chromatography in protein separations - synthesis and characterization of aprotinin derivatives and homologues
Wenzel, 1985
Platelet preservation during cardiopulmonary bypass with aprotinin.
Wildevuur CR, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W., Eur J Cardiothorac Surg 3(6), 1989
PMID: 2483979
IgE-mediated anaphylactic reaction to aprotinin during anaesthesia.
Wuthrich B, Schmid P, Schmid ER, Tornic M, Johansson SG., Lancet 340(8812), 1992
PMID: 1378167
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 9043935
PubMed | Europe PMC

Suchen in

Google Scholar